Avion Pharmaceuticals, LLC et al v. Lupin Limited et al
| Avion Pharmaceuticals, LLC and Albion Laboratories, Inc. |
| Lupin Limited and Lupin Pharmaceuticals, Inc. |
| 1:2022cv00729 |
| June 2, 2022 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 28, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 15
Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 9/1/2022 at 10:00 AM Telephonically before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 7/28/2022. (nmf)
|
| Pro Hac Vice Attorney Michael A. Meneghini for Lupin Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Pro Hac Vice Attorney Kurt A. Mathas for Lupin Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Filing 14 MOTION for Pro Hac Vice Appearance of Attorney Michael K. Nutter, Kurt A. Mathas and Michael A. Meneghini - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: #1 Certification of Michael K. Nutter, #2 Certification of Kurt A. Mathas, #3 Certification of Michael A. Meneghini)(Bilson, David) |
|
SO ORDERED, re #14 MOTION for Pro Hac Vice Appearance of Attorney Michael K. Nutter, Kurt A. Mathas and Michael A. Meneghini, filed by Lupin Limited, Lupin Pharmaceuticals, Inc. Ordered by Judge Colm F. Connolly on 7/19/2022. (kmd)
|
| Filing 13 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Limited for Lupin Pharmaceuticals, Inc. filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Phillips, John) |
| Filing 12 ANSWER to #1 Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Lupin Pharmaceuticals, Inc., Lupin Limited.(Phillips, John) |
| Pro Hac Vice Attorney Autumn N. Nero, Andrew T. Dufrense, PhD, and Olivia Radics for Avion Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Pro Hac Vice Attorney Andrew T. Dufrense, PhD for Avion Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Filing 11 WAIVER OF SERVICE returned executed by Avion Pharmaceuticals, LLC: For Lupin Pharmaceuticals, Inc. waiver sent on 6/27/2022, answer due 8/26/2022. (Stamoulis, Stamatios) |
| Filing 10 WAIVER OF SERVICE returned executed by Avion Pharmaceuticals, LLC: For Lupin Limited waiver sent on 6/27/2022, answer due 9/26/2022. (Stamoulis, Stamatios) |
|
SO ORDERED, re #9 MOTION for Pro Hac Vice Appearance of Attorney Autumn N. Nero, Olivia Radics, and Andrew T. Dufrense, Ph.D., filed by Avion Pharmaceuticals, LLC. Ordered by Judge Colm F. Connolly on 6/10/2022. (kmd)
|
| Filing 9 MOTION for Pro Hac Vice Appearance of Attorney Autumn N. Nero, Olivia Radics, and Andrew T. Dufrense, Ph.D. - filed by Avion Pharmaceuticals, LLC. (Stamoulis, Stamatios) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Filing 8 Summons Issued as to Lupin Limited on 6/3/2022. (twk) |
| Filing 7 Summons Issued as to Lupin Pharmaceuticals, Inc. on 6/3/2022. (twk) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Balchem Corporation for Albion Laboratories, Inc. filed by Albion Laboratories, Inc.. (twk) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parents Acella Holdings, LLC, Alora Pharmaceuticals, LLC for Avion Pharmaceuticals, LLC filed by Avion Pharmaceuticals, LLC. (twk) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,838,042 B2. (twk) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: April 19, 2022. Date of Expiration of Patent: June 1, 2027. Thirty Month Stay Deadline: 10/19/2024. (twk) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Filing 1 COMPLAINT filed against Lupin Limited, Lupin Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-3887827.) - filed by Avion Pharmaceuticals, LLC, Albion Laboratories, Inc.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(twk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
